CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Oct. 31, 2023 USD ($)	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)
Operating activities:
Net (loss) income	$ (575)	$ 69,244	$ 1,047
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Net loss (gain) on sale of Maryland properties	1,003	(68,771)
Depreciation	2,944	3,995	9,300
Amortization	612	1,104	1,653
Stock based compensation expense	11	1,192	42
Directors fees and related interest paid in stock units	26	120	446
Stock awards granted to directors	140
Loss on investment in tenancy-in-common	271	228	295
Deferred rents - straight line rent	100	(18)	230
Deferred real estate tax appeal fees		35
Bad debt expense	16	361	361
Accreted interest on investment in U.S. Treasury securities	(353)
Changes in operating assets and liabilities:
Tenants' security accounts	(23)	(754)	(75)
Accounts receivable, prepaid expenses and other assets	152	2,571	(363)
Accounts payable, accrued expenses and deferred director compensation payable	(1,954)	(1,159)	(7)
Deferred revenue	311	(786)	100
Due to affiliate - accrued interest		(47)	(808)
Deferred interest on mortgages			(2)
Net cash provided by operating activities	2,681	7,315	12,219
Investing activities:
(Cash outlays) proceeds from sale of Maryland properties, net	(1,003)	245,763
Purchase of U.S. Treasury securities	(38,444)
Proceeds from maturities of U.S. Treasury securities	15,204
Proceeds from payment of secured loans receivable inclusive of accrued interest		5,316
Capital improvements - existing properties	(1,290)	(1,570)	(1,936)
Deferred leasing costs	(170)	(173)	(279)
Distribution from investment in tenancy-in-common	390	357	423
Net cash (used in) provided by investing activities	(25,313)	249,693	(1,792)
Financing activities:
Repayment of mortgages	(26,538)	(194,559)	(5,962)
Proceeds from mortgage loan refinancings	25,500	32,500
Proceeds from exercise of stock options	1,263	2,028
Deferred financing costs	(481)	(691)	(699)
Due to affiliate - loan proceeds		300
Due to affiliate - loan repayment		(3,505)	(1,861)
Dividends paid	(13,721)	(53,535)	(1,027)
Distributions to noncontrolling interests in subsidiaries	(3,535)	(20,091)	(1,350)
Net cash used in financing activities	(17,512)	(237,553)	(10,899)
Net (decrease) increase in cash, cash equivalents and restricted cash	(40,144)	19,455	(472)
Cash, cash equivalents and restricted cash, beginning of year	58,500	39,045	39,517
Cash, cash equivalents and restricted cash, end of year	18,356	58,500	39,045
Supplemental disclosure of cash flow data:
Interest paid	7,182	7,134	10,965
Operating activities:
Commercial tenant security deposits applied to accounts receivable			10
Investing activities:
Accrued capital expenditures, construction costs and pre-development costs	210	33	125
Financing activities:
Retirement of treasury stock			2,791
Dividends declared but not paid	372	10,573	686
Dividends paid in share units		1,741	42
Vested share units issued to retired director			72
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents	13,217	49,578	35,891
Tenants' security accounts	962	1,038	1,340
Funds held in post-closing escrow	883	6,251
Mortgage escrows (included in prepaid expenses and other assets)	3,294	1,633	1,814
Total cash, cash equivalents and restricted cash	$ 18,356	$ 58,500	$ 39,045